Zhenghai Huang

Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Integrated 18F-NOTA-FAPI-04 PET/MRI for quantitative assessment of disease activity in thyroid-associated ophthalmopathy.

Integrated 18F-NOTA-FAPI-04 PET/MRI for quantitative assessment of disease activity in thyroid-associated ophthalmopathy.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 08, 2026

Beyond tumor tracing: physiological uptake of sympathetic ganglia on somatostatin receptor PET/CT - prevalence, patterns, and biological rationale.

Beyond tumor tracing: physiological uptake of sympathetic ganglia on somatostatin receptor PET/CT - prevalence, patterns, and biological rationale.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 19, 2026

Standardized quantification of [18F]Florbetazine amyloid PET with the Centiloid scale.

Standardized quantification of [18F]Florbetazine amyloid PET with the Centiloid scale.

Journal: NeuroImage

Published: October 12, 2025

The integrated diagnostic strategy of performing PSMA PET/CT followed by MRI improves the diagnostic accuracy of prostate cancer.

The integrated diagnostic strategy of performing PSMA PET/CT followed by MRI improves the diagnostic accuracy of prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 06, 2025

Assessment of the diagnostic efficacy and clinical significance of [18F]AlF-NOTA-LM3 PET/CT in patients with well-differentiated neuroendocrine tumors.

Assessment of the diagnostic efficacy and clinical significance of [18F]AlF-NOTA-LM3 PET/CT in patients with well-differentiated neuroendocrine tumors.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 27, 2025

The diagnostic performance of [18F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir.

The diagnostic performance of [18F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [11C]PiB and [18F]Florbetapir.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 22, 2025

Feasibility of simplified Patlak parametric imaging with scaled population-based input function on pancreatic cancer.

Feasibility of simplified Patlak parametric imaging with scaled population-based input function on pancreatic cancer.

Journal: EJNMMI physics

Published: September 17, 2024

Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system.

Ultra-fast [18F]florbetapir PET imaging using the uMI Panorama PET/CT system.

Journal: EJNMMI physics

Published: August 04, 2024

Feasibility of a deep-inspiration breath-hold [18F]AlF-NOTA-LM3 PET/CT imaging on upper-abdominal lesions in NET patients: in comparison with respiratory-gated PET/CT.

Feasibility of a deep-inspiration breath-hold [18F]AlF-NOTA-LM3 PET/CT imaging on upper-abdominal lesions in NET patients: in comparison with respiratory-gated PET/CT.

Journal: EJNMMI physics

Published: April 14, 2024

Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification.

Evaluation of a novel PET tracer [18F]-Florbetazine for Alzheimer's disease diagnosis and β-amyloid deposition quantification.

Journal: NeuroImage

Published: March 12, 2024

Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.

Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NOTA-LM3 and head-to-head comparison with [68Ga]Ga-DOTATATE in patients with well-differentiated neuroendocrine tumors: an interim analysis of a prospective trial.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 06, 2024

Pharmacometabolomics in Endogenous Drugs: A New Approach for Predicting the Individualized Pharmacokinetics of Cholic Acid.

Pharmacometabolomics in Endogenous Drugs: A New Approach for Predicting the Individualized Pharmacokinetics of Cholic Acid.

Journal: Journal of proteome research

Published: August 26, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026